Why Early Detection—and Expert Treatment—Makes Skin Cancer Different

As a dermatologic surgeon, I see firsthand the impact of skin cancer on patients’ lives. While skin cancer is the most common cancer in the United States and worldwide, it is often less deadly than breast, prostate, or lung cancer. The primary reason for this difference is not that skin cancer is inherently less dangerous, but that it is more visible and accessible for early detection—and that dermatologists have played a pivotal role in this success story.

Skin Cancer: The Most Common Cancer, but Not the Deadliest

Each year, millions of Americans are diagnosed with skin cancer. Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC)—the two most common types—affect more people than all other cancers combined. Melanoma, while less common, is far more aggressive and responsible for the majority of skin cancer deaths.

Compare this to the annual U.S. statistics for other major cancers:

• Breast cancer: ≈300,000 new cases, 43,000 deaths
• Prostate cancer: ≈288,000 new cases, 35,000 deaths
• Lung cancer: ≈238,000 new cases, 127,000 deaths

Despite its overwhelming prevalence, skin cancer causes far fewer deaths. The reason? Early detection.

The Power of Early Detection

Unlike cancers that develop deep within the body, skin cancers are visible on the surface. This visibility allows for earlier recognition, diagnosis, and intervention—often before the cancer has a chance to spread or cause life-threatening harm. The majority of skin cancers are found at a stage when they are highly curable, and this is largely due to the vigilance of patients, primary care providers, and, most importantly, dermatologists.

Dermatologists are uniquely trained to recognize subtle changes in the skin, distinguish benign from malignant lesions, and perform biopsies and definitive treatments. Their expertise is central to the high survival rates seen in skin cancer, especially when compared to cancers that are typically diagnosed at a later, less treatable stage.

The Role of Dermatologists and Micrographic Dermatologic Surgeons

While early detection is critical for survival, the quality of treatment determines the long-term outcome for function and appearance. This is where micrographic dermatologic surgeons—fellowship-trained experts in Mohs surgery—make a profound difference.

Micrographic Dermatologic Surgery (Mohs Surgery):

• Highest cure rates: Up to 99% for primary BCC and SCC, even in high-risk or recurrent cases.
• Tissue preservation: Removes only cancerous tissue, sparing healthy skin and minimizing scarring—vital for the face, hands, and other sensitive areas.
• Immediate reconstruction: Allows for optimal cosmetic and functional repair at the time of tumor removal.
• No chemotherapy or radiation: Most cases are cured without the need for systemic therapies, reducing side effects and long-term risks.
• Safety and efficiency: Performed under local anesthesia in an outpatient setting, with rapid recovery.

The expertise of micrographic dermatologic surgeons is pivotal in reducing the risk of recurrence, loss of function, and disfigurement. Their meticulous approach ensures that cancer is completely removed while preserving as much healthy tissue as possible—a balance that is especially important for tumors on the nose, eyelids, lips, and ears.

The Ongoing Challenge

Despite these successes, skin cancer remains a public health challenge. Incidence rates continue to rise, partly due to increased awareness and screening, but also because of lifestyle and environmental factors. While population-wide screening has not yet been shown to reduce mortality, the individualized, expert care provided by dermatologists and micrographic surgeons has been instrumental in improving outcomes.

The Bottom Line

Skin cancer is common, but it does not have to be deadly or disfiguring. The key difference lies in early detection and expert treatment. Dermatologists have led the way in improving survival, and micrographic dermatologic surgeons have set the standard for preserving function and appearance. As we continue to educate, screen, and treat, we can further reduce the burden of this disease—one patient at a time.

Your skin is your first line of defense—protect it, examine it, and trust it to the hands of experts.